Top insider buys, last 30 days
The 50 highest-scoring open-market purchases by company insiders reported on SEC Form 4, delayed 48 hours. Updated Oct 24, 2026 04:22 UTC.
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 80 | ACCV | Accelevation Holdings Corp. | Rubiera Michael | CEO | 2026-10-01 | $3.60M | 16% | 5 insiders |
| 79 | RAPP | Rapport Therapeutics, Inc. | Ignelzi Troy A. | CFO | 2026-10-21 | $144K | 55% | 6 insiders |
| 78 | HEI | HEICO CORP | Mendelson Victor H | CEO | 2026-10-08 | $175K | new | 8 insiders |
| 76 | ADRX | ADARx Pharmaceuticals, Inc. | George Simeon | Director | 2026-09-28 | $10.07M | new | 5 insiders |
| 76 | ADRX | ADARx Pharmaceuticals, Inc. | Gordon Carl L | Director | 2026-09-28 | $10.00M | new | 5 insiders |
| 76 | ADRX | ADARx Pharmaceuticals, Inc. | Orbimed Advisors Llc / Orbimed Capital Gp Vii Llc / Orbimed Israel Gp Ii, L.P. / Orbimed Advisors Israel Ii Ltd / Orbimed Genesis Gp Llc | Director | 2026-09-28 | $10.00M | new | 5 insiders |
| 76 | ACCV | Accelevation Holdings Corp. | Rubiera Michael | CEO | 2026-10-01 | $58K | new | 5 insiders |
| 74 | ADRX | ADARx Pharmaceuticals, Inc. | Sr One Capital Management, Llc | 10% Owner | 2026-09-28 | $10.07M | new | 5 insiders |
| 73 | XENE | Xenon Pharmaceuticals Inc. | Mortimer Ian | CEO | 2026-09-30 | $1.12M | 151% | 2 insiders |
| 72 | PORT.U | Southport Acquisition Corp. II | Spencer Jeb S. / Southport Sponsor Management Ii, Llc | CEO | 2026-09-30 | $5.00M | new | 2 insiders |
| 72 | ADRX | ADARx Pharmaceuticals, Inc. | George Simeon | Director | 2026-09-28 | $7.05M | 27% | 5 insiders |
| 70 | HEI | HEICO CORP | Fine Carol F. | Director | 2026-10-08 | $175K | 118% | 8 insiders |
| 70 | HEI | HEICO CORP | Schriesheim Alan | Director | 2026-10-08 | $175K | 195% | 8 insiders |
| 70 | HEI | HEICO CORP | Neitzel Julie | Director | 2026-10-08 | $175K | 142% | 8 insiders |
| 70 | PRHI | Presurance Holdings, Inc. | Meloche Harold J | CFO | 2026-09-30 | $26K | 40% | 5 insiders |
| 70 | GPUS | Hyperscale Data, Inc. | Ault Milton C Iii / Ault & Company, Inc. | Chair | 2026-09-30 | $5.00M | 255% | 2 insiders |
| 70 | ADRX | ADARx Pharmaceuticals, Inc. | Sr One Capital Management, Llc | 10% Owner | 2026-09-28 | $7.05M | 27% | 5 insiders |
| 69 | AGMB | AgomAb Therapeutics NV | Knotnerus Tim Jasper | CEO | 2026-10-05 | $51K | 55% | 3 insiders |
| 69 | ADRX | ADARx Pharmaceuticals, Inc. | George Simeon | Director | 2026-09-28 | $10.07M | 12% | 5 insiders |
| 69 | FUL | FULLER H B CO | Florness Daniel L | Director | 2026-09-28 | $100K | 150% | 8 insiders |
| 69 | FUL | FULLER H B CO | Lauber Charles T | Director | 2026-09-29 | $100K | 148% | 8 insiders |
| 69 | ATCH | AtlasClear Holdings, Inc. | Hammond Thomas Jon | Director | 2026-09-24 | $100K | 70822% | 5 insiders |
| 69 | FUL | FULLER H B CO | Happe Michael J | Director | 2026-09-29 | $99K | 149% | 8 insiders |
| 69 | FUL | FULLER H B CO | Zaheer Srilata | Director | 2026-09-28 | $98K | 149% | 8 insiders |
| 69 | BBD | BANK BRADESCO | Alvarez Rubens Aguiar | Director | 2026-09-01 | $29.49M | 85% | 2 insiders |
| 68 | FUL | FULLER H B CO | Rasmussen Trangsrud Teresa J | Director | 2026-09-28 | $75K | 77% | 8 insiders |
| 68 | FUL | FULLER H B CO | Bailly R Jeffrey | Director | 2026-10-07 | $500K | new | 9 insiders |
| 68 | REF | Reformation Inc. | Coyle John Joseph | Director | 2026-07-31 | $3.00M | 302% | 3 insiders |
| 68 | PRHI | Presurance Holdings, Inc. | Roney Brian J | CEO | 2026-09-30 | $51K | 10% | 5 insiders |
| 67 | DKS | DICK'S SPORTING GOODS, INC. | Barnes Matthew | President | 2026-09-30 | $500K | 44% | 3 insiders |
| 67 | PRHI | Presurance Holdings, Inc. | O'Hanlon Isolde | Director | 2026-09-30 | $49K | 1015% | 5 insiders |
| 67 | PRHI | Presurance Holdings, Inc. | Smith James Grant | Director | 2026-09-30 | $49K | 83% | 5 insiders |
| 67 | ADRX | ADARx Pharmaceuticals, Inc. | Sr One Capital Management, Llc | 10% Owner | 2026-09-28 | $10.07M | 12% | 5 insiders |
| 67 | AGMB | AgomAb Therapeutics NV | Kemula Pierre Thadee Victor | CFO | 2026-10-06 | $43K | 167% | 3 insiders |
| 67 | BPRE | Bluerock Private Real Estate Fund | Kamfar Ramin | Director | 2026-09-23 | $1.87M | 83% | 3 insiders |
| 66 | GME | GameStop Corp. | Cohen Ryan | CEO | 2026-10-13 | $20.98M | 2% | 2 insiders |
| 66 | GME | GameStop Corp. | Cohen Ryan | CEO | 2026-10-02 | $17.08M | 2% | 2 insiders |
| 66 | BPRE | Bluerock Private Real Estate Fund | Kamfar Ramin | Director | 2026-09-22 | $1.34M | 165% | 3 insiders |
| 66 | ACCV | Accelevation Holdings Corp. | Jones Ginger M | Director | 2026-10-01 | $180K | new | 5 insiders |
| 65 | DX | DYNEX CAPITAL INC | Popenoe Smriti Laxman | CEO | 2026-10-20 | $50K | new | 3 insiders |
| 65 | ADRX | ADARx Pharmaceuticals, Inc. | Gordon Carl L | Director | 2026-09-28 | $5.10M | 2% | 5 insiders |
| 65 | ADRX | ADARx Pharmaceuticals, Inc. | Orbimed Advisors Llc / Orbimed Capital Gp Vii Llc / Orbimed Israel Gp Ii, L.P. / Orbimed Advisors Israel Ii Ltd / Orbimed Genesis Gp Llc | Director | 2026-09-28 | $5.10M | 2% | 5 insiders |
| 65 | ACCV | Accelevation Holdings Corp. | Donahue Paul D | Director | 2026-10-01 | $126K | new | 5 insiders |
| 64 | GME | GameStop Corp. | Cohen Ryan | CEO | 2026-09-29 | $10.48M | 1% | 2 insiders |
| 64 | FUL | FULLER H B CO | Handley Thomas W | Director | 2026-09-28 | $99K | new | 8 insiders |
| 64 | ACCV | Accelevation Holdings Corp. | Heckes Howard C | Director | 2026-10-01 | $90K | new | 5 insiders |
| 64 | XENE | Xenon Pharmaceuticals Inc. | Kelly Thomas Patrick | CFO | 2026-09-30 | $560K | new | 2 insiders |
| 63 | BORR | Borr Drilling Ltd | Snowling Harvey Edward | Officer | 2026-10-14 | $1.47M | 206% | 2 insiders |
| 62 | DKS | DICK'S SPORTING GOODS, INC. | Gupta Navdeep | CFO | 2026-09-22 | $1000K | 10% | 3 insiders |
| 62 | N | John Hancock GA Mortgage Trust | Manulife (International) Ltd | 10% Owner | 2026-09-30 | $26.00M | 3% | 4 insiders |
Want them the morning after they're filed? Get the daily alerts.